Correction: PetLife Pharmaceuticals Enters Negotiations with Key Founders of InnoVision Therapeutics to Discuss Expansion of its Core Product Line
December 07, 2016 08:50 ET
|
PetLife Pharmaceuticals, Inc.
Hancock, MD, Dec. 07, 2016 (GLOBE NEWSWIRE) -- PetLife Pharmaceuticals, Inc. (OTC QB: PTLF) (the "Company"), a developer of a new generation of high potency veterinary cancer medications and...
PetLife Pharmaceuticals Updates Shareholders on the Company Progress with Vitalzul™ Studies and Additional Product Offerings
December 01, 2016 08:00 ET
|
PetLife Pharmaceuticals, Inc.
Hancock, MD, Dec. 01, 2016 (GLOBE NEWSWIRE) -- PetLife Pharmaceuticals, Inc. (OTC QB: PTLF) (the "Company"), a developer of a new generation of high potency veterinary cancer medications and...
PetLife Pharmaceuticals is Pleased to Announce the Completion of the New Company Website
October 17, 2016 08:00 ET
|
PetLife Pharmaceuticals, Inc.
Hancock, MD, Oct. 17, 2016 (GLOBE NEWSWIRE) -- PetLife Pharmaceuticals, Inc. (OTC QB: PTLF) (the "Company"), a developer of a new generation of high potency veterinary cancer medications and...
PetLife Pharmaceuticals Expands Cell Line Study with InnoVision in Preparation for FDA/CVM Registration Submission
October 13, 2016 08:00 ET
|
PetLife Pharmaceuticals, Inc.
Hancock, MD, Oct. 13, 2016 (GLOBE NEWSWIRE) -- PetLife Pharmaceuticals, Inc. (OTC QB: PTLF) (the "Company"), a developer of a new generation of high potency veterinary cancer medications and...